Version 2.77

Maturity: Beta

  1. The LOINC Groups project is a work in progress. The contents of this file may change from release to release as we receive feedback from users and refine our processes.
  2. The contents of the file and the groupings MUST be validated by the user prior to implementation in any aspect of clinical care. We have created Groups that may be useful in specific contexts, but these Groups have not been vetted for use in either patient care or research and should be used with caution.
  3. More information on LOINC Groups is available on our website.

Basic Attributes

Version First Released
Pending promotion to Production status (Beta)
Parent Group
LG80-4  Drug/ToxPotentialForAbuse<SAME:Comp><ROLLUP:Prop|Tm|Sys|Meth>
Group Category
Drugs of abuse

LOINC Terminology Service (API) using HL7® FHIR® Get Info

ValueSet definition
https://fhir.loinc.org/ValueSet/?url=http://loinc.org/vs/LG37590-3
ValueSet expansion
https://fhir.loinc.org/ValueSet/$expand?url=http://loinc.org/vs/LG37590-3

LOINC terms in Group

LOINC Long Common Name
14066-5 Dihydrocodeine [Presence] in Urine
14067-3 Dihydrocodeine [Mass/volume] in Blood
16211-5 Dihydrocodeine [Presence] in Urine by Confirmatory method
19446-4 Dihydrocodeine [Presence] in Urine by Screen method
19448-0 Dihydrocodeine [Mass/volume] in Urine by Confirmatory method
19449-8 Dihydrocodeine [Mass/volume] in Urine
42901-9 Dihydrocodeine [Mass/volume] in Serum or Plasma
74811-1 Dihydrocodeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
86227-6 Dihydrocodeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method